Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-03-22
2005-03-22
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S513000, C514S255040, C514S263350, C514S297000, C514S303000, C514S423000, C514S459000, C544S049000, C544S271000, C544S396000, C546S106000, C546S113000, C548S533000, C549S049000, C549S292000, C558S254000, C558S255000, C560S055000, C560S255000
Reexamination Certificate
active
06869974
ABSTRACT:
Compounds or their salts having general formulas (I) and (II): wherein s is an integer equal to 1 or 2, A is the radical of a drug that satisfies certain pharmacological tests, C and C1are bivalent radicals, and precursors of the radicals B and B1satisfy certain pharmacological tests.
REFERENCES:
patent: 5861426 (1999-01-01), Del Soldato et al.
patent: 0 012 866 (1980-07-01), None
patent: WO 9412463 (1994-06-01), None
patent: WO 9509831 (1995-04-01), None
patent: WO 9530641 (1995-11-01), None
Pathophysiology: The Biologic Basis for Disease in Adults and Children, McCance & Huether, 1998, pp 71-77 and p. 1025.
K. B. Schwarz, “Oxidative Stress During Viral Infection: A Review”, Free Radical Biology & Medicine, vol. 21, No. 5, 1996, pp. 641-649.
F. E. Silverstein et al, “Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs”, Annals of Internal Medicine, vol. 123, No. 4, Aug. 15, 1995, pp 241-249.
Martindale—The Extra Pharmacopoeia, 31st Edition, 1996, Nonsteroidal Anti-inflammatory Drugs, p. 73.
Current Medical Diagnosis & Treatment 1998, 37th Edition, a Lange Medical Book, p. 431 and p. 794.
H. G. Utley et al, “Effect of Sulfhydryl Reagents on Peroxidation in Microsomes”, Archives of Biochemistry and Biophysics, vol. 118, 1997, pp. 29-32.
M. S. Nenseter et al, “Paracetamol Inhibits Copper Ion-Induced, Azo Compound-Initiated, and Mononuclear Cell-Mediated Oxidative Modification of LDL”, Atheroscler. Thromb. 15, 1995, pp 1338-1344.
Brändström et al, “Chemical Reactions of Omeprazole and Omeprazole Analogues”, Acta Chemica Scandinavica, vol. 43, 1989, pp 549-568.
Baylis et al, “Chronic Blockade of Nitric Oxide Synthesis in the Rat Producers Systemic Hypertension and Glomerular Damage”, J. Clin. Investigation, vol. 90, 1992, pp 278-281.
Edwards et al, “The Formation of a Structure with the Features of Synovial Lining by Subcutaneous Injection of Air: An In Vivo Tissue Culture System”, J. Pathology, vol. 134, 1981, pp. 147-156.
Arent & Fox PLLC
Nicox S.A.
Raymond Richard L.
LandOfFree
Pharmaceutical compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3455673